Why Is Psychedelic-SciSparc Stock Trading Higher On Monday? SciSparc teams up with Clearmind Medicine on innovative therapies for binge behaviors and secures FDA approval for a Tourette Syndrome ...
Analysts Cut Price Targets For Praxis Precision After Trial Setback For Essential Tremor Candidate Praxis Precision Medicines' ulixacaltamide study for essential tremor faces setback as IDMC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback